TCR recognition of peptide/MHC class II complexes and superantigens
- PMID: 17560120
- PMCID: PMC2949352
- DOI: 10.1016/j.smim.2007.04.006
TCR recognition of peptide/MHC class II complexes and superantigens
Abstract
Major histocompatibility complex (MHC) class II molecules display peptides to the T cell receptor (TCR). The ability of the TCR to discriminate foreign from self-peptides presented by MHC molecules is a requirement of an effective adaptive immune response. Dysregulation of this molecular recognition event often leads to a disease state. Recently, a number of structural studies have provided significant insight into several such dysregulated interactions between peptide/MHC complexes and TCR molecules. These include TCR recognition of self-peptides, which results in autoimmune reactions, and of mutant self-peptides, common in the immunosurveillance of tumors, as well as the engagement of TCRs by superantigens, a family of bacterial toxins responsible for toxic shock syndrome.
Figures
References
-
- Rosenberg SA. Progress in human tumour immunology and immunotherapy. Nature. 2001;411(6835):380–4. - PubMed
-
- Engelhorn ME, et al. Autoimmunity and tumor immunity induced by immune responses to mutations in self. Nat Med. 2006;12(2):198–206. - PubMed
-
- Rudolph MG, et al. How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol. 2006;24:419–66. - PubMed
-
- Sospedra M, et al. Immunology of multiple sclerosis. Annu Rev Immunol. 2005;23:683–747. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
